Xgeva



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Metastases To Bone 28.5%
Product Used For Unknown Indication 25.4%
Prostate Cancer 8.6%
Breast Cancer 6.8%
Breast Cancer Metastatic 6.7%
Prophylaxis 5.9%
Prostate Cancer Metastatic 5.7%
Pain 1.8%
Bone Disorder 1.6%
Hypertension 1.5%
Lung Neoplasm Malignant 1.4%
Neoplasm Malignant 1.2%
Osteoporosis 0.9%
Chemotherapy 0.7%
Renal Cell Carcinoma 0.7%
Hypocalcaemia 0.6%
Lung Cancer Metastatic 0.6%
Supplementation Therapy 0.5%
Bone Giant Cell Tumour 0.5%
Hypothyroidism 0.5%
Hypocalcaemia 23.6%
Osteonecrosis Of Jaw 22.4%
Death 14.0%
Bone Pain 4.6%
Pain In Jaw 3.8%
Tooth Disorder 3.8%
Hypophosphataemia 3.4%
Dyspnoea 2.7%
Incorrect Route Of Drug Administration 2.6%
Rash 2.6%
Blood Calcium Decreased 2.2%
Neoplasm Malignant 1.9%
Pain 1.9%
Hypercalcaemia 1.6%
Vomiting 1.6%
Fatigue 1.6%
Toothache 1.5%
Hospitalisation 1.4%
Muscle Spasms 1.4%
Paraesthesia 1.4%
Secondary
Metastases To Bone 27.1%
Product Used For Unknown Indication 18.3%
Prostate Cancer 13.3%
Breast Cancer Metastatic 6.7%
Breast Cancer 6.3%
Prostate Cancer Metastatic 5.9%
Pain 4.3%
Prophylaxis 3.4%
Osteoporosis 2.3%
Lung Neoplasm Malignant 2.0%
Lung Cancer Metastatic 1.4%
Hypertension 1.2%
Chemotherapy 1.1%
Nausea 1.1%
Osteoporosis Postmenopausal 1.1%
Fibrous Dysplasia Of Bone 1.0%
Hypercalcaemia 1.0%
Atrial Fibrillation 0.9%
Breast Cancer Recurrent 0.9%
Bone Disorder 0.7%
Osteonecrosis Of Jaw 22.7%
Hypocalcaemia 13.6%
Death 7.4%
Tremor 5.7%
Paraesthesia 4.5%
Spinal Fracture 4.5%
Bone Pain 4.0%
Dyspnoea 4.0%
Muscle Spasms 4.0%
Pain 4.0%
Fall 3.4%
Pain In Jaw 3.4%
Fatigue 2.8%
Rash 2.8%
Tooth Disorder 2.8%
Prothrombin Time Ratio Increased 2.3%
Swelling 2.3%
Toothache 2.3%
Arthralgia 1.7%
Groin Pain 1.7%
Concomitant
Product Used For Unknown Indication 50.6%
Prostate Cancer 11.2%
Breast Cancer Metastatic 5.2%
Prostate Cancer Metastatic 4.3%
Breast Cancer 3.9%
Metastases To Bone 3.4%
Pain 3.3%
Prophylaxis 2.9%
Nausea 2.9%
Hypertension 2.3%
Supplementation Therapy 2.1%
Constipation 1.0%
Anxiety 1.0%
Bone Disorder 0.9%
Depression 0.9%
Non-small Cell Lung Cancer 0.9%
Gastrooesophageal Reflux Disease 0.8%
Lung Neoplasm Malignant 0.8%
Diabetes Mellitus 0.8%
Chronic Obstructive Pulmonary Disease 0.7%
Weight Decreased 13.7%
Vomiting 8.4%
Death 7.6%
Prostatic Specific Antigen Increased 7.6%
Disease Progression 6.1%
Nausea 6.1%
Diarrhoea 5.3%
Respiratory Failure 5.3%
Prostate Cancer 3.8%
Stomatitis 3.8%
Thrombocytopenia 3.8%
Vision Blurred 3.8%
Malignant Neoplasm Progression 3.1%
Pain 3.1%
Pain In Extremity 3.1%
Pneumonia 3.1%
Pyrexia 3.1%
Urticaria 3.1%
Weight Increased 3.1%
White Blood Cell Count Decreased 3.1%